| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.687 | 0.004 | 0.687 | 5 Hydroxytryptamine 7 antagonist | 0.177 0.015 DBMET01389 0.251 0.008 DBMET01388 0.442 0.005 DBMET01391 0.108 0.024 DBMET01390 | ||
| 0.679 | 0.003 | 0.679 | 5 Hydroxytryptamine uptake inhibitor | 0.312 0.005 DBMET01389 0.304 0.006 DBMET01388 0.472 0.004 DBMET01391 0.246 0.008 DBMET01390 | ||
| 0.435 | 0.005 | 0.435 | 5 Hydroxytryptamine 1A agonist | 0.056 0.026 DBMET01389 0.059 0.025 DBMET01388 0.172 0.01 DBMET01391 | ||
| 0.41 | 0.002 | 0.41 | Integrin alphaLbeta2 antagonist | 0.248 0.002 DBMET01389 0.232 0.003 DBMET01388 0.37 0.002 DBMET01391 0.254 0.002 DBMET01390 | ||
| 0.385 | 0.002 | 0.385 | 5 Hydroxytryptamine 3A agonist | 0.15 0.035 DBMET01389 0.245 0.006 DBMET01388 0.28 0.004 DBMET01391 0.144 0.039 DBMET01390 | ||
| 0.385 | 0.005 | 0.493 | 5 Hydroxytryptamine agonist | 0.255 0.01 DBMET01389 0.26 0.01 DBMET01388 0.493 0.005 DBMET01391 0.161 0.019 DBMET01390 | DBMET01391 | |
| 0.403 | 0.023 | 0.403 | Calcium channel activator | 0.244 0.154 DBMET01389 0.213 0.194 DBMET01388 0.264 0.131 DBMET01391 0.233 0.168 DBMET01390 | ||
| 0.39 | 0.012 | 0.39 | 5 Hydroxytryptamine antagonist | |||
| 0.421 | 0.083 | 0.421 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.351 0.149 DBMET01391 0.327 0.178 DBMET01390 | ||
| 0.338 | 0.003 | 0.338 | 5 Hydroxytryptamine 3 agonist | 0.082 0.025 DBMET01389 0.097 0.017 DBMET01388 0.137 0.006 DBMET01391 0.067 0.039 DBMET01390 | ||
| 0.3 | 0.004 | 0.3 | 5 Hydroxytryptamine 1B agonist | 0.089 0.009 DBMET01389 0.084 0.011 DBMET01388 0.122 0.005 DBMET01391 0.073 0.016 DBMET01390 | ||
| 0.291 | 0.003 | 0.291 | 5 Hydroxytryptamine 3A antagonist | 0.061 0.054 DBMET01388 0.113 0.011 DBMET01391 | ||
| 0.285 | 0.004 | 0.285 | 5 Hydroxytryptamine 1D antagonist | 0.076 0.034 DBMET01391 | ||
| 0.317 | 0.037 | 0.317 | 5 Hydroxytryptamine uptake stimulant | 0.2 0.152 DBMET01389 0.201 0.149 DBMET01388 0.225 0.11 DBMET01391 0.266 0.067 DBMET01390 | ||
| 0.283 | 0.004 | 0.283 | 5 Hydroxytryptamine 3 antagonist | 0.065 0.031 DBMET01391 | ||
| 0.276 | 0.011 | 0.276 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.27 | 0.008 | 0.27 | 5 Hydroxytryptamine 1 agonist | 0.056 0.034 DBMET01391 | ||
| 0.324 | 0.063 | 0.324 | 5 Hydroxytryptamine release stimulant | |||
| 0.335 | 0.083 | 0.335 | Thioredoxin glutathione reductase inhibitor | 0.219 0.156 DBMET01388 0.207 0.167 DBMET01391 | ||
| 0.277 | 0.047 | 0.277 | 5 Hydroxytryptamine 1E antagonist | 0.181 0.153 DBMET01388 0.173 0.162 DBMET01391 | ||
| 0.245 | 0.019 | 0.245 | 5 Hydroxytryptamine 3E antagonist | 0.163 0.161 DBMET01389 0.164 0.157 DBMET01388 0.217 0.04 DBMET01391 | ||
| 0.213 | 0.014 | 0.213 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.248 | 0.059 | 0.248 | Neuropeptide Y2 antagonist | 0.185 0.149 DBMET01388 0.207 0.108 DBMET01391 | ||
| 0.259 | 0.075 | 0.259 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.241 0.081 DBMET01388 0.176 0.116 DBMET01391 0.164 0.127 DBMET01390 | ||
| 0.19 | 0.01 | 0.19 | Cell adhesion molecule inhibitor | 0.107 0.03 DBMET01389 0.104 0.032 DBMET01388 0.118 0.025 DBMET01391 0.143 0.017 DBMET01390 | ||
| 0.287 | 0.108 | 0.287 | Prostaglandin dehydrogenase inhibitor | 0.181 0.172 DBMET01388 | ||
| 0.248 | 0.076 | 0.248 | Superoxide dismutase inhibitor | 0.202 0.115 DBMET01390 | ||
| 0.176 | 0.004 | 0.176 | 5 Hydroxytryptamine 6 antagonist | 0.067 0.031 DBMET01391 | ||
| 0.201 | 0.035 | 0.201 | Toll-Like receptor 9 antagonist | |||
| 0.179 | 0.02 | 0.179 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.195 | 0.038 | 0.227 | Hexokinase inhibitor | 0.176 0.053 DBMET01389 0.19 0.041 DBMET01388 0.158 0.07 DBMET01391 0.227 0.023 DBMET01390 | DBMET01390 | |
| 0.181 | 0.027 | 0.181 | Cyclooxygenase 3 inhibitor | 0.126 0.071 DBMET01389 0.136 0.061 DBMET01388 0.133 0.064 DBMET01391 0.172 0.032 DBMET01390 | ||
| 0.156 | 0.005 | 0.156 | 5 Hydroxytryptamine 2C agonist | |||
| 0.156 | 0.007 | 0.156 | 5 Hydroxytryptamine 5A antagonist | 0.057 0.05 DBMET01391 | ||
| 0.173 | 0.032 | 0.173 | Aurora-A kinase inhibitor | |||
| 0.146 | 0.008 | 0.146 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.169 | 0.036 | 0.169 | Cell adhesion inhibitor | 0.112 0.072 DBMET01389 0.107 0.078 DBMET01388 0.102 0.085 DBMET01391 0.149 0.047 DBMET01390 | ||
| 0.17 | 0.038 | 0.17 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.14 | 0.01 | 0.14 | Adrenaline uptake inhibitor | |||
| 0.196 | 0.075 | 0.196 | Histone acetyltransferase inhibitor | |||
| 0.211 | 0.094 | 0.211 | MAP kinase kinase 3 inhibitor | 0.194 0.142 DBMET01391 | ||
| 0.121 | 0.014 | 0.121 | Dopamine uptake inhibitor | |||
| 0.133 | 0.03 | 0.133 | DNA directed RNA polymerase inhibitor | |||
| 0.12 | 0.017 | 0.12 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.269 | 0.168 | 0.269 | MAP kinase kinase 6 inhibitor | |||
| 0.132 | 0.033 | 0.132 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.101 | 0.009 | 0.101 | 5 Hydroxytryptamine 2 agonist | 0.046 0.042 DBMET01389 0.06 0.027 DBMET01388 0.087 0.013 DBMET01391 | ||
| 0.268 | 0.177 | 0.268 | Alpha-glucosidase inhibitor | |||
| 0.208 | 0.122 | 0.208 | Tyrosine 3 hydroxylase inhibitor | 0.206 0.126 DBMET01388 | ||
| 0.176 | 0.093 | 0.176 | Growth factor agonist | 0.158 0.125 DBMET01389 | ||
| 0.215 | 0.135 | 0.215 | Insulysin inhibitor | 0.206 0.148 DBMET01390 | ||
| 0.262 | 0.185 | 0.262 | DNA polymerase beta inhibitor | |||
| 0.089 | 0.012 | 0.089 | Glucosylceramidase inhibitor | 0.077 0.017 DBMET01389 | ||
| 0.089 | 0.015 | 0.089 | Heat shock protein 90 beta antagonist | 0.074 0.025 DBMET01388 | ||
| 0.235 | 0.169 | 0.235 | GABA C receptor rho-3 antagonist | |||
| 0.167 | 0.102 | 0.167 | I kappa B kinase epsilon inhibitor | |||
| 0.23 | 0.167 | 0.23 | Beta lactamase inhibitor | |||
| 0.141 | 0.079 | 0.141 | Neuropeptide Y1 antagonist | |||
| 0.098 | 0.037 | 0.098 | Histamine H2 receptor antagonist | |||
| 0.138 | 0.077 | 0.138 | Activin receptor-like kinase 2 inhibitor | |||
| 0.074 | 0.016 | 0.074 | 5 Hydroxytryptamine 7 agonist | |||
| 0.109 | 0.051 | 0.109 | Antiadrenergic | |||
| 0.107 | 0.05 | 0.107 | Adrenaline antagonist | |||
| 0.106 | 0.05 | 0.106 | Phosphodiesterase 7B inhibitor | |||
| 0.075 | 0.021 | 0.075 | Beta 1 adrenoreceptor antagonist | 0.053 0.042 DBMET01389 0.053 0.043 DBMET01388 | ||
| 0.101 | 0.047 | 0.101 | Alpha 2d adrenoreceptor antagonist | |||
| 0.081 | 0.027 | 0.081 | 5 Hydroxytryptamine 2A agonist | |||
| 0.071 | 0.017 | 0.071 | Epithelial sodium channel blocker | |||
| 0.201 | 0.15 | 0.201 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.19 | 0.14 | 0.19 | Streptokinase A inhibitor | |||
| 0.092 | 0.044 | 0.092 | Inducible nitric-oxide synthase inhibitor | |||
| 0.161 | 0.114 | 0.161 | Focal adhesion kinase 2 inhibitor | |||
| 0.203 | 0.157 | 0.203 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.129 | 0.084 | 0.129 | Protein kinase (CK1) inhibitor | |||
| 0.055 | 0.01 | 0.055 | 5 Hydroxytryptamine 2B agonist | 0.049 0.014 DBMET01391 | ||
| 0.135 | 0.095 | 0.135 | Heat shock protein 70 antagonist | 0.135 0.094 DBMET01390 | ||
| 0.054 | 0.014 | 0.054 | Alpha 1d adrenoreceptor agonist | |||
| 0.062 | 0.024 | 0.062 | Integrin antagonist | |||
| 0.099 | 0.062 | 0.099 | Nitric-oxide synthase inhibitor | |||
| 0.05 | 0.013 | 0.05 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.148 | 0.111 | 0.148 | Phospholipase C inhibitor | |||
| 0.12 | 0.085 | 0.12 | Toll-Like receptor antagonist | |||
| 0.059 | 0.025 | 0.059 | Beta 2 adrenoreceptor antagonist | |||
| 0.205 | 0.171 | 0.205 | Vasodilator, peripheral | |||
| 0.049 | 0.018 | 0.049 | Alpha 1L adrenoreceptor agonist | |||
| 0.055 | 0.025 | 0.055 | Sodium/calcium exchanger inhibitor | |||
| 0.117 | 0.087 | 0.117 | NADPH oxidase inhibitor | |||
| 0.064 | 0.034 | 0.064 | Cyclin H inhibitor | |||
| 0.135 | 0.106 | 0.135 | CF transmembrane conductance regulator agonist | |||
| 0.038 | 0.009 | 0.038 | LFA antagonist | 0.036 0.01 DBMET01390 | ||
| 0.144 | 0.117 | 0.144 | Neurotensin receptor agonist | |||
| 0.051 | 0.023 | 0.051 | Purinergic P2X4 antagonist | |||
| 0.128 | 0.101 | 0.128 | Heat shock protein 90 antagonist | |||
| 0.231 | 0.204 | 0.231 | DNA directed DNA polymerase inhibitor | |||
| 0.055 | 0.029 | 0.055 | Phosphodiesterase 7A inhibitor | |||
| 0.129 | 0.103 | 0.129 | Pregnane X receptor agonist | |||
| 0.123 | 0.097 | 0.123 | Cytidine deaminase inhibitor | |||
| 0.053 | 0.029 | 0.053 | Alpha 1b adrenoreceptor agonist | |||
| 0.063 | 0.039 | 0.063 | Alpha 2 adrenoreceptor agonist | |||
| 0.099 | 0.076 | 0.099 | Alpha 2b adrenoreceptor antagonist | |||
| 0.028 | 0.004 | 0.028 | Integrin beta2 antagonist | 0.013 0.008 DBMET01389 0.013 0.008 DBMET01390 | ||
| 0.034 | 0.01 | 0.034 | Estrogen-related receptor gamma antagonist | 0.029 0.017 DBMET01388 | ||
| 0.071 | 0.049 | 0.071 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.066 | 0.045 | 0.066 | Beta adrenoreceptor antagonist | 0.06 0.055 DBMET01388 | ||
| 0.121 | 0.101 | 0.13 | Farnesoid X receptor antagonist | 0.13 0.082 DBMET01388 0.127 0.088 DBMET01390 | DBMET01388 | |
| 0.074 | 0.054 | 0.074 | CYP2A6 inhibitor | |||
| 0.134 | 0.115 | 0.134 | LIM domain kinase 1 inhibitor | |||
| 0.028 | 0.008 | 0.028 | ICAM 1 antagonist | |||
| 0.037 | 0.018 | 0.037 | Purinergic P2Y2 antagonist | 0.031 0.028 DBMET01391 0.037 0.019 DBMET01390 | ||
| 0.027 | 0.008 | 0.027 | Imidazoline I1 receptor antagonist | |||
| 0.032 | 0.014 | 0.032 | 5 Hydroxytryptamine 6 agonist | |||
| 0.193 | 0.176 | 0.193 | Transcription factor NF kappa B inhibitor | |||
| 0.042 | 0.026 | 0.046 | Nicotinic acid receptor 1 agonist | 0.046 0.022 DBMET01390 | DBMET01390 | |
| 0.095 | 0.079 | 0.095 | Beta glucuronidase inhibitor | |||
| 0.03 | 0.014 | 0.03 | Myristoyl transferase inhibitor | |||
| 0.038 | 0.022 | 0.038 | Glycine transporter 1 inhibitor | |||
| 0.069 | 0.056 | 0.069 | Phospholipase D inhibitor | |||
| 0.071 | 0.06 | 0.071 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.074 | 0.065 | 0.074 | Acetylcholine nicotinic agonist | |||
| 0.029 | 0.023 | 0.029 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.054 | 0.048 | 0.054 | Carbonic anhydrase stimulant | |||
| 0.129 | 0.124 | 0.147 | Ca2+-transporting ATPase inhibitor | 0.147 0.05 DBMET01390 | DBMET01390 | |
| 0.073 | 0.069 | 0.073 | ALK inhibitor | |||
| 0.017 | 0.013 | 0.017 | Sodium/hydrogen exchanger inhibitor | |||
| 0.077 | 0.074 | 0.077 | Alpha adrenoreceptor antagonist | |||
| 0.215 | 0.213 | 0.215 | Transcription factor inhibitor | |||
| 0.113 | 0.113 | 0.116 | Mannose-6-phosphate isomerase inhibitor | 0.116 0.109 DBMET01390 | DBMET01390 | |
| 0.019 | 0.023 | 0.064 | Retinoid X gamma receptor agonist | 0.021 0.018 DBMET01389 0.064 0.005 DBMET01390 | DBMET01390 | |
| 0.017 | 0.022 | 0.059 | Retinoid X beta receptor agonist | 0.02 0.015 DBMET01389 0.059 0.004 DBMET01390 | DBMET01390 | |
| 0.027 | 0.04 | 0.034 | Estrogen-related receptor beta antagonist | 0.034 0.019 DBMET01388 | DBMET01388 | |
| 0.082 | 0.095 | 0.154 | Ferrochelatase inhibitor | 0.154 0.036 DBMET01390 | DBMET01390 | |
| 0.016 | 0.032 | 0.028 | Retinoid X beta receptor antagonist | 0.028 0.005 DBMET01390 | DBMET01390 | |
| 0.022 | 0.038 | 0.035 | Retinoid X gamma receptor antagonist | 0.035 0.007 DBMET01390 | DBMET01390 | |
| 0.086 | 0.112 | 0.155 | M18 aspartyl aminopeptidase inhibitor | 0.155 0.049 DBMET01388 | DBMET01388 | |
| 0.028 | 0.056 | 0.053 | Retinoid X receptor antagonist | 0.053 0.01 DBMET01390 | DBMET01390 | |
| 0.025 | 0.054 | 0.046 | Retinoid X alpha receptor antagonist | 0.046 0.009 DBMET01390 | DBMET01390 | |
| 0.102 | 0.132 | 0.19 | Cell wall synthesis inhibitor | 0.157 0.059 DBMET01389 0.113 0.111 DBMET01388 0.121 0.099 DBMET01391 0.19 0.034 DBMET01390 | DBMET01390 | |
| 0.074 | 0.105 | 0.09 | GABA C receptor agonist | 0.09 0.079 DBMET01390 | DBMET01390 | |
| 0.076 | 0.108 | 0.107 | Electrolyte absorption antagonist | 0.107 0.049 DBMET01390 | DBMET01390 | |
| 0.047 | 0.091 | 0.131 | Porphobilinogen synthase inhibitor | 0.065 0.061 DBMET01389 0.131 0.025 DBMET01390 | DBMET01390 | |
| 0.018 | 0.065 | 0.033 | Purinergic P2Y14 antagonist | 0.033 0.018 DBMET01390 | DBMET01390 | |
| 0.036 | 0.084 | 0.084 | Biliverdin reductase inhibitor | 0.084 0.024 DBMET01390 | DBMET01390 | |
| 0.018 | 0.069 | 0.053 | Retinoid X alpha receptor agonist | 0.053 0.013 DBMET01390 | DBMET01390 | |
| 0.042 | 0.095 | 0.062 | Phenylalanine 4-hydroxylase inhibitor | 0.062 0.055 DBMET01390 | DBMET01390 | |
| 0.065 | 0.12 | 0.092 | NADH dehydrogenase inhibitor | 0.092 0.053 DBMET01390 | DBMET01390 | |
| 0.206 | 0.264 | 0.317 | Calcium channel L-type activator | 0.317 0.143 DBMET01389 0.235 0.222 DBMET01390 | DBMET01389 | |
| 0.063 | 0.122 | 0.101 | Triose-phosphate isomerase inhibitor | 0.101 0.047 DBMET01390 | DBMET01390 | |
| 0.115 | 0.181 | 0.169 | Aldehyde oxidase inhibitor | 0.169 0.124 DBMET01390 | DBMET01390 | |
| 0.092 | 0.161 | 0.137 | Mcl-1 antagonist | 0.137 0.104 DBMET01390 | DBMET01390 | |
| 0.076 | 0.149 | 0.175 | Alpha-N-acetylglucosaminidase inhibitor | 0.175 0.043 DBMET01390 | DBMET01390 | |
| 0.071 | 0.153 | 0.103 | Adenylate kinase inhibitor | 0.103 0.063 DBMET01390 | DBMET01390 | |
| 0.011 | 0.095 | 0.042 | Retinoid X receptor agonist | 0.042 0.021 DBMET01390 | DBMET01390 | |
| 0.036 | 0.125 | 0.06 | Purinergic P2X1 antagonist | 0.06 0.043 DBMET01390 | DBMET01390 | |
| 0.026 | 0.117 | 0.044 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.044 0.023 DBMET01390 | DBMET01390 | |
| 0.057 | 0.152 | 0.083 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.083 0.075 DBMET01390 | DBMET01390 | |
| 0.162 | 0.279 | 0.365 | Antibacterial | 0.26 0.167 DBMET01389 0.277 0.153 DBMET01388 0.218 0.209 DBMET01391 0.365 0.093 DBMET01390 | DBMET01390 | |
| 0.04 | 0.159 | 0.068 | Glutamate dehydrogenase inhibitor | 0.068 0.059 DBMET01390 | DBMET01390 | |
| 0.048 | 0.182 | 0.116 | Uric acid excretion stimulant | 0.116 0.04 DBMET01390 | DBMET01390 | |
| 0.022 | 0.18 | 0.051 | Aconitate hydratase inhibitor | 0.051 0.037 DBMET01390 | DBMET01390 | |
| 0.09 | 0.273 | 0.151 | Succinate dehydrogenase inhibitor | 0.151 0.11 DBMET01390 | DBMET01390 | |
| 0.101 | 0.284 | 0.304 | Lipoxygenase inhibitor | 0.245 0.104 DBMET01389 0.304 0.069 DBMET01388 0.202 0.138 DBMET01391 0.232 0.112 DBMET01390 | DBMET01388 | |
| 0.024 | 0.211 | 0.064 | Glutamate decarboxylase inhibitor | 0.064 0.063 DBMET01390 | DBMET01390 | |
| 0.032 | 0.235 | 0.059 | Adenine nucleotide translocase inhibitor | 0.059 0.029 DBMET01390 | DBMET01390 | |
| 0.03 | 0.249 | 0.295 | Ca(v)2.2 blocker | 0.197 0.017 DBMET01389 0.214 0.014 DBMET01388 0.295 0.005 DBMET01391 0.198 0.017 DBMET01390 | DBMET01391 | |
| 0.007 | 0.237 | 0.023 | Retinoic acid receptor agonist | 0.023 0.015 DBMET01390 | DBMET01390 | |
| 0.097 | 0.343 | 0.186 | Cholesterol antagonist | 0.186 0.178 DBMET01390 | DBMET01390 | |
| 0.007 | 0.266 | 0.021 | Retinoic acid beta receptor agonist | 0.021 0.012 DBMET01390 | DBMET01390 | |
| 0.02 | 0.291 | 0.089 | Thrombin inhibitor | 0.073 0.05 DBMET01389 0.075 0.047 DBMET01388 0.089 0.033 DBMET01391 0.074 0.049 DBMET01390 | DBMET01391 | |
| 0.008 | 0.285 | 0.023 | Retinoic acid gamma receptor agonist | 0.023 0.015 DBMET01390 | DBMET01390 | |
| 0.116 | 0.409 | 0.255 | Interleukin 2 agonist | 0.255 0.113 DBMET01389 | DBMET01389 | |
| 0.018 | 0.359 | 0.261 | 5-Lipoxygenase inhibitor | 0.224 0.02 DBMET01389 0.261 0.014 DBMET01388 0.229 0.019 DBMET01391 0.221 0.02 DBMET01390 | DBMET01388 | |
| 0.027 | 0.395 | 0.095 | Estrogen receptor beta antagonist | 0.095 0.074 DBMET01388 | DBMET01388 | |
| 0.082 | 0.453 | 0.213 | Sodium/bile acid cotransporter inhibitor | 0.213 0.171 DBMET01390 | DBMET01390 | |
| 0.008 | 0.432 | 0.045 | Retinoic acid alpha receptor agonist | 0.045 0.019 DBMET01390 | DBMET01390 | |
| 0.03 | 0.459 | 0.1 | Estrogen antagonist | 0.1 0.099 DBMET01388 | DBMET01388 | |
| 0.022 | 0.49 | 0.213 | Bone formation stimulant | 0.209 0.033 DBMET01389 0.213 0.032 DBMET01388 0.21 0.033 DBMET01391 0.208 0.034 DBMET01390 | DBMET01388 | |
| 0.017 | 0.511 | 0.09 | Trypsin inhibitor | 0.074 0.03 DBMET01389 0.077 0.029 DBMET01388 0.09 0.022 DBMET01391 0.087 0.023 DBMET01390 | DBMET01391 | |
| 0.011 | 0.741 | 0.325 | Antioxidant | 0.255 0.081 DBMET01389 0.325 0.053 DBMET01388 0.199 0.114 DBMET01391 0.239 0.09 DBMET01390 | DBMET01388 | |
| 0.005 | 0.78 | 0.095 | Bronchodilator | 0.095 0.07 DBMET01389 | DBMET01389 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |